To R (2024): Personalised adjuvant chemotherapy in stage II colon cancer: a health economic analysis
Similar Tracks
Watch Dr. Liu discuss #NSCLC updates from #ASCO24 - https://bit.ly/2024BiomarkersY
PeerView Oncology
MACSQuant® Tyto® Cell Sorter:Validating a fluorescence sorter for infectious diseases [WEBINAR]
Miltenyi Biotec
Dr. Bernardo Huberman: How to Use Curiosity & Focus to Create a Joyful & Meaningful Life
Andrew Huberman